Avaliação de Prejuízo Cognitivo em Sobreviventes de Câncer de Mama: Estudo Transversal
Authors:
- Renata Nunes PedrasRPRenata Nunes Pedras
- Maria Fernanda Marcusso ManhãesMMMaria Fernanda Marcusso Manhães
- Aline Millani CarneiroACAline Millani Carneiro
- Getulio Yuzo OkumaGOGetulio Yuzo Okuma
- Simone EliasSESimone Elias
- Edvane Birelo Lopes De DomenicoEDEdvane Birelo Lopes De Domenico
- Cristiane Decat BergerotCBCristiane Decat Bergerot
Open Access
- 1 January 2022
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Psicologia: Teoria e Pesquisa
- Vol. 38
Abstract
Resumo Estudo prospectivo e transversal, para determinar a prevalência de prejuízo cognitivo decorrente da quimioterapia e explorar fatores preditores e mediadores em sobreviventes de câncer de mama. Utilizou-se o Termômetro de Distress, Escala de Ansiedade e Depressão, Functional Assessment of Chronic Illness Therapy-General e Cognitive Function. As sobreviventes (N = 62) reportaram uma alta prevalência de distress (46,8%) e de ansiedade (24,2%), com baixos escores nas subescalas déficit cognitivo e habilidades cognitivas percebidos. O funcionamento cognitivo esteve associado à idade (β = 1,42; p = 0,002), atuação profissional (β = -23,12; p = 0,004), depressão (β = -5,43; p = 0,001) e qualidade de vida (β = 1,24; p = 0,001). Prejuízo cognitivo deve ser considerado no serviço de Psico-Oncologia.Keywords
This publication has 25 references indexed in Scilit:
- Psychosocial/Survivorship Issues in Breast Cancer: Are We Doing Better?JNCI: Journal of the National Cancer Institute, 2014
- Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instrumentsPsycho-Oncology, 2013
- Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysisThe Lancet Oncology, 2013
- Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancerHuman Brain Mapping, 2011
- Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practicePsycho-Oncology, 2011
- Engaging neuroscience to advance translational research in brain barrier biologyNature Reviews Neuroscience, 2011
- Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trialPsycho-Oncology, 2010
- Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care responseJournal of Cancer Survivorship, 2009
- Neurotoxicology of Chemotherapy in Relation to Cytokine Release, the Blood-Brain Barrier, and Cognitive ImpairmentOncology Nursing Forum, 2008
- Renaming “Chemobrain”Cancer Investigation, 2007